Teva Pharmaceutical: Generic Market Access to Global Healthcare Industry

Neta Kela

A chapter in Healthcare Access from IntechOpen

Abstract: The present paper represents a qualitative case study on the pharmaceutical company Teva, including an in-depth exploration of the company within the specific context of pharmaceutical industry. Being a qualitative case study in the business discipline, the company details regarding the shareholders, the stock price fluctuations in recent decades in comparison with other competitors will be presented. The objective of this article is to provide a thorough description of Teva, a global leader in the pharmaceutical industry, by assessing the evolution of the company considering the changes at the corporate level and in the market, like the appearances of new competitors. The results will contribute in providing an insight in how future pharma companies can avoid certain pitfalls and how they should reply to the market competition and different other changes on the market.

Keywords: Pharmaceutical; market access; healthcare; global industry (search for similar items in EconPapers)
JEL-codes: I11 (search for similar items in EconPapers)
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.intechopen.com/chapters/77028 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ito:pchaps:235566

DOI: 10.5772/intechopen.97747

Access Statistics for this chapter

More chapters in Chapters from IntechOpen
Bibliographic data for series maintained by Slobodan Momcilovic ().